Abstract:BACKGROUND: Currently, the identification of accurate biomarkers for the diagnosis of patients with early-stage lung cancer remains difficult. Fortunately, metabolomics technology can be used to improve the detection of plasma metabolic biomarkers for lung cancer. In a previous study, we successfully utilised machine learning methods to identify significant metabolic markers for early-stage lung cancer diagnosis. However, a related research platform for the investigation of tumour metabolism and drug efficacy is still lacking.HYPOTHESIS/PURPOSE: A novel methodology for the comprehensive evaluation of the internal tumour-metabolic profile and drug evaluation needs to be established.METHODS: The optimal location for tumour cell inoculation was identified in mouse chest for the non-traumatic orthotopic lung cancer mouse model. Microcomputed tomography (micro-CT) was applied to monitor lung tumour growth. Proscillaridin A (P.A) and cisplatin (CDDP) were utilised to verify the anti-lung cancer efficacy of the platform. The top five clinically valid biomarkers, including proline, L-kynurenine, spermidine, taurine and palmitoyl-L-carnitine, were selected as the evaluation indices to obtain a suitable lung cancer mouse model for clinical metabolomics research by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).RESULTS: The platform was successfully established, achieving 100% tumour development rate and 0% surgery mortality. P.A and CDDP had significant anti-lung cancer efficacy in the platform. Compared with the control group, four biomarkers in the orthotopic model and two biomarkers in the metastatic model had significantly higher abundance. Principal component analysis (PCA) showed a significant separation between the orthotopic/metastatic model and the control/subcutaneous/KRAS transgenic model. The platform was mainly involved in arginine and proline metabolism, tryptophan metabolism, and taurine and hypotaurine metabolism.CONCLUSION: This study is the first to simulate clinical metabolomics by comparing the metabolic phenotype of plasma in different lung cancer mouse models. We found that the orthotopic model was the most suitable for tumour metabolism. Furthermore, the anti-tumour drug efficacy was verified in the platform. The platform can very well match the clinical reality, providing better lung cancer diagnosis and securing more precise evidence for drug evaluation in the future.

Metabolic Shifts Induced by Human H460 Cells in Tumor-Bearing Mice.

GC/MS-Based Analysis of Fatty Acids and Amino Acids in H460 Cells Treated with Short-Chain and Polyunsaturated Fatty Acids: A Highly Sensitive Approach.

Dynamic Metabolic Transformation in Tumor Invasion and Metastasis in Mice with Lm-8 Osteosarcoma Cell Transplantation

A Study of the Metabolism of Transplanted Tumor in the Lung by Micro PET/CT in Mice

Metabolomics Reveals That Tumor Xenografts Induce Liver Dysfunction.

Tumor Growth Affects the Metabonomic Phenotypes of Multiple Mouse Non-Involved Organs in an A549 Lung Cancer Xenograft Model

Effect of Short-Chain Fatty Acids and Polyunsaturated Fatty Acids on Metabolites in H460 Lung Cancer Cells

Time-course changes in potential biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats.

1H-Nmr-based Metabolic Profiling of a Colorectal Cancer CT-26 Lung Metastasis Model in Mice.

Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human

Presence of human breast cancer xenograft changes the diurnal profile of amino acids in mice

Dynamic Changes of the Gut Microbiota and Its Functional Metagenomic Potential during the Development of Non-Small Cell Lung Cancer

Establishment of Three Human Pancreatic Cancer Orthotopic Xenograft Nude Mice Models and Serum Metabolomics

Dynamic Metabolic Change is Indicative of Inflammation-Induced Transformation of Hepatic Cells

Non-targeted Metabolomics-based Exploration of Radiation-induced Metabolic Alterations in Mouse Lung Epithelial Cells

Early Response Monitoring Following Radiation Therapy by Using [18F]FDG and [11c]acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration

A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy

Murine Microenvironment Metaprofiles Associate with Human Cancer Etiology and Intrinsic Subtypes

Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD<sub>82</sub> Cell Line

Targeted Metabolic Analysis of Nucleotides and Identification of Biomarkers Associated with Cancer in Cultured Cell Models

Metabonomic Studies of Pancreatic Cancer Response to Radiotherapy in a Mouse Xenograft Model Using Magnetic Resonance Spectroscopy and Principal Components Analysis